Molecular and Cellular Biochemistry

, Volume 421, Issue 1–2, pp 89–101 | Cite as

Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells

  • Sayantanee Das
  • Scott M. Filippone
  • Denise S. Williams
  • Anindita Das
  • Rakesh C. KukrejaEmail author


Doxorubicin (DOX, Adriamycin) is a broad-spectrum chemotherapeutic drug used to treat a variety of cancers, although its clinical use is restricted by irreversible cardiotoxicity. Earlier studies show that beet root juice (BRJ), a natural and safe herbal product with high levels of nitrate and antioxidants, is a potent chemopreventive agent; however, its cardioprotective function is yet to be established. The goal of this study was to determine the protective effect of BRJ against DOX-induced cardiotoxicity, and its effect on DOX-induced cytotoxicity in MDA-MB-231 breast cancer cells. Adult rat cardiomyocytes and MDA-MB-231 cells were exposed to different concentrations of BRJ (0.5, 5, 50, 250, and 500 µg/ml) with or without DOX. Cell death, measured by trypan blue staining, was significantly reduced in cardiomyocytes but increased in MDA-MB-231 following 24 h of co-treatment with BRJ and DOX. Cell viability was also significantly reduced after BRJ and DOX co-treatment in MDA-MB-231 cells. Similarly, DOX-induced apoptosis, as determined by TUNEL assay, was significantly reduced following treatment with BRJ for 48 h in cardiomyocytes. In contrast, BRJ significantly increased DOX-mediated apoptosis in cancer cells with activation of poly(ADP-ribose) polymerase (PARP) and increased the Bax:Bcl-2 ratio. DOX-induced generation of reactive oxygen species (ROS) was reduced following co-treatment with BRJ in cardiomyocytes but increased dose-dependently with BRJ in MDA-MB-231 cells. In conclusion, lower concentrations of BRJ with DOX represented the most effective combination of cardioprotection and chemoprevention. These findings provide insight into the possible cardioprotective ability of BRJ in cancer patients treated with anthracycline chemotherapeutic drugs.


Apoptosis Beet root juice Breast cancer cells Cardiomyocytes Doxorubicin Reactive oxygen species 



This work was supported by grants from the National Institutes of Health R37HL51045 and RO1 HL118808 to Dr. Rakesh C Kukreja.

Compliance with ethical standards

Conflict of interest

The authors state no conflict of interest.


  1. 1.
    Bristow MR, Mason JW, Billingham ME, Daniels JR (1978) Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med 88:168–175CrossRefPubMedGoogle Scholar
  2. 2.
    Konorev EA, Kotamraju S, Zhao H, Kalivendi S, Joseph J, Kalyanaraman B (2002) Paradoxical effects of metalloporphyrins on doxorubicin-induced apoptosis: scavenging of reactive oxygen species versus induction of heme oxygenase-1. Free Radic Biol Med 33:988CrossRefPubMedGoogle Scholar
  3. 3.
    Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339:900–905CrossRefPubMedGoogle Scholar
  4. 4.
    Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229CrossRefPubMedGoogle Scholar
  5. 5.
    Simunek T, Sterba M, Popelova O, Adamcova M, Hrdina R, Gersl V (2009) Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61:154–171CrossRefPubMedGoogle Scholar
  6. 6.
    Minotti G, Cairo G, Monti E (1999) Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J 13:199–212PubMedGoogle Scholar
  7. 7.
    Myers C (1998) The role of iron in doxorubicin-induced cardiomyopathy. Semin Oncol 25:10–14PubMedGoogle Scholar
  8. 8.
    Guo W, Kong E, Meydani M (2009) Dietary polyphenols, inflammation, and cancer. Nutr Cancer 61:807–810CrossRefPubMedGoogle Scholar
  9. 9.
    Ziech D, Franco R, Georgakilas AG, Georgakila S, Malamou-Mitsi V, Schoneveld O, Pappa A, Panayiotidis MI (2010) The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact 188:334–339CrossRefPubMedGoogle Scholar
  10. 10.
    Ludke A, Sharma AK, Bagchi AK, Singal PK (2012) Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes. Mol Cell Biochem 360:215–224CrossRefPubMedGoogle Scholar
  11. 11.
    Parry J, Su L, Moore J, Cheng Z, Luther M, Rao JN, Wang JY, Yu LL (2006) Chemical compositions, antioxidant capacities, and antiproliferative activities of selected fruit seed flours. J Agric Food Chem 54:3773–3778CrossRefPubMedGoogle Scholar
  12. 12.
    Alkreathy H, Damanhouri ZA, Ahmed N, Slevin M, Ali SS, Osman AM (2010) Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol 48:951–956CrossRefPubMedGoogle Scholar
  13. 13.
    Alkreathy HM, Damanhouri ZA, Ahmed N, Slevin M, Osman AM (2012) Mechanisms of cardioprotective effect of aged garlic extract against doxorubicin-induced cardiotoxicity. Integr Cancer Ther 11:364–370CrossRefPubMedGoogle Scholar
  14. 14.
    Siveski-Iliskovic N, Hill M, Chow DA, Singal PK (1995) Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 91:10–15CrossRefPubMedGoogle Scholar
  15. 15.
    Lechner JF, Wang LS, Rocha CM, Larue B, Henry C, McIntyre CM, Riedl KM, Schwartz SJ, Stoner GD (2010) Drinking water with red beetroot food color antagonizes esophageal carcinogenesis in N-nitrosomethylbenzylamine-treated rats. J Med Food 13:733–739CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Escribano J, Gandia-Herrero F, Caballero N, Pedreno MA (2002) Subcellular localization and isoenzyme pattern of peroxidase and polyphenol oxidase in beet root (Beta vulgaris L.). J Agric Food Chem 50:6123–6129CrossRefPubMedGoogle Scholar
  17. 17.
    Kapadia GJ, Azuine MA, Rao GS, Arai T, Iida A, Tokuda H (2011) Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines. Anticancer Agents Med Chem 11:280–284CrossRefPubMedGoogle Scholar
  18. 18.
    Kazimierczak R, Hallmann E, Lipowski J, Drela N, Kowalik A, Pussa T, Matt D, Luik A, Gozdowski D, Rembialkowska E (2014) Beetroot (Beta vulgaris L.) and naturally fermented beetroot juices from organic and conventional production: metabolomics, antioxidant levels and anticancer activity. J Sci Food Agric 94:2618–2629CrossRefPubMedGoogle Scholar
  19. 19.
    Vulic JJ, Cebovic TN, Canadanovic VM, Cetkovic GS, Djilas SM, Canadanovic-Brunet JM, Velicanski AS, Cvetkovic DD, Tumbas VT (2013) Antiradical, antimicrobial and cytotoxic activities of commercial beetroot pomace. Food Funct 4:713–721CrossRefPubMedGoogle Scholar
  20. 20.
    Kapadia GJ, Tokuda H, Konoshima T, Nishino H (1996) Chemoprevention of lung and skin cancer by Beta vulgaris (beet) root extract. Cancer Lett 100:211–214CrossRefPubMedGoogle Scholar
  21. 21.
    Kapadia GJ, Azuine MA, Sridhar R, Okuda Y, Tsuruta A, Ichiishi E, Mukainake T, Takasaki M, Konoshima T, Nishino H, Tokuda H (2003) Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot. Pharmacol Res 47:141–148CrossRefPubMedGoogle Scholar
  22. 22.
    Salloum FN, Sturz GR, Yin C, Rehman S, Hoke NN, Kukreja RC, Xi L (2015) Beetroot juice reduces infarct size and improves cardiac function following ischemia-reperfusion injury: possible involvement of endogenous H2S. Exp Biol Med (Maywood) 240:669–681CrossRefGoogle Scholar
  23. 23.
    Das A, Xi L, Kukreja RC (2005) Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 280:12944–12955CrossRefPubMedGoogle Scholar
  24. 24.
    Das A, Smolenski A, Lohmann SM, Kukreja RC (2006) Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte. J Biol Chem 281:38644–38652CrossRefPubMedGoogle Scholar
  25. 25.
    Das A, Durrant D, Mitchell C, Mayton E, Hoke NN, Salloum FN, Park MA, Qureshi I, Lee R, Dent P, Kukreja RC (2010) Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. Proc Natl Acad Sci USA 107:18202–18207CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Das A, Durrant D, Mitchell C, Dent P, Batra SK, Kukreja RC (2016) Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95. Oncotarget 7:4399–4413PubMedGoogle Scholar
  27. 27.
    Liu X, Chen Z, Chua CC, Ma YS, Youngberg GA, Hamdy R, Chua BH (2002) Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 283:H254–H263CrossRefPubMedGoogle Scholar
  28. 28.
    Di X, Gennings C, Bear HD, Graham LJ, Sheth CM, White KL Jr, Gewirtz DA (2010) Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells. Breast Cancer Res Treat 124:349–360CrossRefPubMedGoogle Scholar
  29. 29.
    Day TW, Huang S, Safa AR (2008) c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells. Biochem Pharmacol 76:1694–1704CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Petrioli R, Fiaschi AI, Francini E, Pascucci A, Francini G (2008) The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer. Cancer Treat Rev 34:710–718CrossRefPubMedGoogle Scholar
  31. 31.
    Konorev EA, Vanamala S, Kalyanaraman B (2008) Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radic Biol Med 45:1723–1728CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Reeve JL, Szegezdi E, Logue SE, Ni CT, O’Brien T, Ritter T, Samali A (2007) Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL. J Cell Mol Med 11:509–520CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Yamaoka M, Yamaguchi S, Suzuki T, Okuyama M, Nitobe J, Nakamura N, Mitsui Y, Tomoike H (2000) Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J Mol Cell Cardiol 32:881–889CrossRefPubMedGoogle Scholar
  34. 34.
    Wang L, Ma W, Markovich R, Chen JW, Wang PH (1998) Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res 83:516–522CrossRefPubMedGoogle Scholar
  35. 35.
    Wang L, Ma W, Markovich R, Lee WL, Wang PH (1998) Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 139:1354–1360PubMedGoogle Scholar
  36. 36.
    Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y, Simon AR, Evans T, Suzuki YJ (2003) Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 63:368–377CrossRefPubMedGoogle Scholar
  37. 37.
    Kitta K, Day RM, Kim Y, Torregroza I, Evans T, Suzuki YJ (2003) Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 278:4705–4712CrossRefPubMedGoogle Scholar
  38. 38.
    D’Amours D, Desnoyers S, D’Silva I, Poirier GG (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342(Pt 2):249–268CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Satoh MS, Lindahl T (1992) Role of poly(ADP-ribose) formation in DNA repair. Nature 356:356–358CrossRefPubMedGoogle Scholar
  40. 40.
    Satoh MS, Poirier GG, Lindahl T (1994) Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry 33:7099–7106CrossRefPubMedGoogle Scholar
  41. 41.
    Shall S, de Murcia G (2000) Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 460:1–15CrossRefPubMedGoogle Scholar
  42. 42.
    d’Adda di FF, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP (1999) Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet 23:76–80Google Scholar
  43. 43.
    de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 94:7303–7307CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Trucco C, Oliver FJ, de Murcia G, Menissier-de MJ (1998) DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Res 26:2644–2649CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Vodenicharov MD, Sallmann FR, Satoh MS, Poirier GG (2000) Base excision repair is efficient in cells lacking poly(ADP-ribose) polymerase 1. Nucleic Acids Res 28:3887–3896CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49:5870–5878PubMedGoogle Scholar
  47. 47.
    Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976–3985PubMedGoogle Scholar
  48. 48.
    Germain M, Affar EB, D’Amours D, Dixit VM, Salvesen GS, Poirier GG (1999) Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 274:28379–28384CrossRefPubMedGoogle Scholar
  49. 49.
    Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346–347CrossRefPubMedGoogle Scholar
  50. 50.
    Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37–43CrossRefPubMedGoogle Scholar
  51. 51.
    D’Amours D, Sallmann FR, Dixit VM, Poirier GG (2001) Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114:3771–3778PubMedGoogle Scholar
  52. 52.
    Zhou S, Palmeira CM, Wallace KB (2001) Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol Lett 121:151–157CrossRefPubMedGoogle Scholar
  53. 53.
    Legha SS, Wang YM, Mackay B, Ewer M, Hortobagyi GN, Benjamin RS, Ali MK (1982) Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity. Ann N Y Acad Sci 393:411–418CrossRefPubMedGoogle Scholar
  54. 54.
    Wagdi P, Fluri M, Aeschbacher B, Fikrle A, Meier B (1996) Cardioprotection in patients undergoing chemo- and/or radiotherapy for neoplastic disease. A pilot study. Jpn Heart J 37:353–359CrossRefPubMedGoogle Scholar
  55. 55.
    Berthiaume JM, Wallace KB (2007) Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol 23:15–25CrossRefPubMedGoogle Scholar
  56. 56.
    Chaiswing L, Cole MP, Ittarat W, Szweda LI, St Clair DK, Oberley TD (2005) Manganese superoxide dismutase and inducible nitric oxide synthase modify early oxidative events in acute adriamycin-induced mitochondrial toxicity. Mol Cancer Ther 4:1056–1064CrossRefPubMedGoogle Scholar
  57. 57.
    Lebrecht D, Geist A, Ketelsen UP, Haberstroh J, Setzer B, Walker UA (2007) Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. Br J Pharmacol 151:771–778CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Lichtenthaler R, Marx F (2005) Total oxidant scavenging capacities of common European fruit and vegetable juices. J Agric Food Chem 53:103–110CrossRefPubMedGoogle Scholar
  59. 59.
    Vali L, Stefanovits-Banyai E, Szentmihalyi K, Febel H, Sardi E, Lugasi A, Kocsis I, Blazovics A (2007) Liver-protecting effects of table beet (Beta vulgaris var. rubra) during ischemia-reperfusion. Nutrition 23:172–178CrossRefPubMedGoogle Scholar
  60. 60.
    Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Loukogeorgakis S, MacAllister R, Hobbs AJ, Webb AJ, Ahluwalia A (2010) Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 56:274–281CrossRefPubMedGoogle Scholar
  61. 61.
    Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, Rashid R, Miall P, Deanfield J, Benjamin N, MacAllister R, Hobbs AJ, Ahluwalia A (2008) Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51:784–790CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Bryan NS, Calvert JW, Elrod JW, Gundewar S, Ji SY, Lefer DJ (2007) Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 104:19144–19149CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Nicolay K, Fok JJ, Voorhout W, Post JA, de Kruijff B (1986) Cytofluorescence detection of adriamycin-mitochondria interactions in isolated, perfused rat heart. Biochim Biophys Acta 887:35–41CrossRefPubMedGoogle Scholar
  64. 64.
    Kardeh S, Ashkani-Esfahani S, Alizadeh AM (2014) Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur J Pharmacol 735:150–168CrossRefPubMedGoogle Scholar
  65. 65.
    Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150:12–27CrossRefPubMedGoogle Scholar
  66. 66.
    Wang Q, Liang B, Shirwany NA, Zou MH (2011) 2-Deoxy-d-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase. PLoS One 6:e17234CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Wong CH, Iskandar KB, Yadav SK, Hirpara JL, Loh T, Pervaiz S (2010) Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One 5:e9996CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Kong Q, Lillehei KO (1998) Antioxidant inhibitors for cancer therapy. Med Hypotheses 51:405–409CrossRefPubMedGoogle Scholar
  69. 69.
    Kong Q, Beel JA, Lillehei KO (2000) A threshold concept for cancer therapy. Med Hypotheses 55:29–35CrossRefPubMedGoogle Scholar
  70. 70.
    Hong SW, Jin DH, Hahm ES, Yim SH, Lim JS, Kim KI, Yang Y, Lee SS, Kang JS, Lee WJ, Lee WK, Lee MS (2007) Ascorbate (vitamin C) induces cell death through the apoptosis-inducing factor in human breast cancer cells. Oncol Rep 18:811–815PubMedGoogle Scholar
  71. 71.
    Mathiasen IS, Lademann U, Jaattela M (1999) Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res 59:4848–4856PubMedGoogle Scholar
  72. 72.
    Patacsil D, Osayi S, Tran AT, Saenz F, Yimer L, Shajahan AN, Gokhale PC, Verma M, Clarke R, Chauhan SC, Kumar D (2012) Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells. Genes Nutr 7:83–89CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Sayantanee Das
    • 1
    • 4
  • Scott M. Filippone
    • 1
  • Denise S. Williams
    • 2
  • Anindita Das
    • 1
  • Rakesh C. Kukreja
    • 1
    • 3
    Email author
  1. 1.Division of Cardiology, Department of Internal Medicine, VCU Pauley Heart CenterVirginia Commonwealth UniversityRichmondUSA
  2. 2.Center for Science, Mathematics and TechnologyMills Edwin Godwin High SchoolRichmondUSA
  3. 3.Division of Cardiology, Pauley Heart CenterVirginia Commonwealth UniversityRichmondUSA
  4. 4.Duke UniversityDurhamUSA

Personalised recommendations